Glyburide
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 317976

CAS#: 10238-21-8

Description: Glyburide is an antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide that can potentially be used to decrease cerebral edema. Upon administration, glyburide binds to and blocks the sulfonylurea receptor type 1 (SUR1) subunit of the ATP-sensitive inwardly-rectifying potassium (K(ATP)) channels on the membranes of pancreatic beta cells. This prevents the inward current flow of positively charged potassium (K+) ions into the cell, and induces a calcium ion (Ca2+) influx through voltage-sensitive calcium channels, which triggers exocytosis of insulin-containing granules.


Chemical Structure

img
Glyburide
CAS# 10238-21-8

Theoretical Analysis

MedKoo Cat#: 317976
Name: Glyburide
CAS#: 10238-21-8
Chemical Formula: C23H28ClN3O5S
Exact Mass: 493.14
Molecular Weight: 494.003
Elemental Analysis: C, 55.92; H, 5.71; Cl, 7.18; N, 8.51; O, 16.19; S, 6.49

Price and Availability

Size Price Availability Quantity
5g USD 250 2 Weeks
25g USD 450 2 Weeks
Bulk inquiry

Synonym: Glyburide; Glibenclamide; Glybenclamide; Micronase; Diabeta; HB-420; HB419; HB420; Maninil; Micronase; Neogluconin;

IUPAC/Chemical Name: 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide

InChi Key: ZNNLBTZKUZBEKO-UHFFFAOYSA-N

InChi Code: InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)

SMILES Code: COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) inhibitor. Glibenclamide inhibits P-glycoprotein. Glibenclamide directly binds and blocks the SUR1 subunits of KATP and inhibits the cystic fibrosis transmembrane conductance regulator protein (CFTR).
In vitro activity: Endothelial cells incubated with a pool of NT (normotensive) plasma induce higher NO levels when compared with the PE (preeclamptic) group (p < 0.05) after 40 min of incubation (Figure 2a). In this group, GB (glibenclamide) treatment increased NO levels (p < 0.05) after 20 min of incubation (Figure 2b) compared with cells without treatment. Reference: Antioxidants (Basel). 2022 Aug 20;11(8):1620. https://pubmed.ncbi.nlm.nih.gov/36009339/
In vivo activity: In comparison, a significant difference was observed in the time spent in platform quadrants (P = 0.0077) and platform crossings (P = 0.013) between rats with low-dose sevoflurane–inflicted cognitive impairment which received GBC (glibenclamide) and rats which were administered the same low dose but no GBC. These results show that cognitive impairment in rats developed following inhalation of sevoflurane but that memory deficits improved after GBC administration to cognition-deficient rats. Reference: J Vet Res. 2021 Dec 2;65(4):527-538. https://pubmed.ncbi.nlm.nih.gov/35112009/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 175.0 354.25
Water 0.1 0.20

Preparing Stock Solutions

The following data is based on the product molecular weight 494.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Nunes PR, Bueno Pereira TO, Bertozzi Matheus M, Grandini NA, Siqueira JS, Correa CR, Abbade JF, Sandrim VC. Glibenclamide Increases Nitric Oxide Levels and Decreases Oxidative Stress in an In Vitro Model of Preeclampsia. Antioxidants (Basel). 2022 Aug 20;11(8):1620. doi: 10.3390/antiox11081620. PMID: 36009339; PMCID: PMC9404919. 2. Yang J, Yang J, Huang X, Xiu H, Bai S, Li J, Cai Z, Chen Z, Zhang S, Zhang G. Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway. Mediators Inflamm. 2022 Feb 11;2022:8457010. doi: 10.1155/2022/8457010. PMID: 35185385; PMCID: PMC8856806. 3. Ma Y, Chen X. Glibenclamide Ameliorates the Expression of Neurotrophic Factors in Sevoflurane Anaesthesia-induced Oxidative Stress and Cognitive Impairment in Hippocampal Neurons of Old Rats. J Vet Res. 2021 Dec 2;65(4):527-538. doi: 10.2478/jvetres-2021-0064. PMID: 35112009; PMCID: PMC8775723. 4. Jiang B, Zhang Y, Wang Y, Li Z, Chen Q, Tang J, Zhu G. Glibenclamide Attenuates Neuroinflammation and Promotes Neurological Recovery After Intracerebral Hemorrhage in Aged Rats. Front Aging Neurosci. 2021 Aug 26;13:729652. doi: 10.3389/fnagi.2021.729652. PMID: 34512312; PMCID: PMC8427510.
In vitro protocol: 1. Nunes PR, Bueno Pereira TO, Bertozzi Matheus M, Grandini NA, Siqueira JS, Correa CR, Abbade JF, Sandrim VC. Glibenclamide Increases Nitric Oxide Levels and Decreases Oxidative Stress in an In Vitro Model of Preeclampsia. Antioxidants (Basel). 2022 Aug 20;11(8):1620. doi: 10.3390/antiox11081620. PMID: 36009339; PMCID: PMC9404919. 2. Yang J, Yang J, Huang X, Xiu H, Bai S, Li J, Cai Z, Chen Z, Zhang S, Zhang G. Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway. Mediators Inflamm. 2022 Feb 11;2022:8457010. doi: 10.1155/2022/8457010. PMID: 35185385; PMCID: PMC8856806.
In vivo protocol: 1. Ma Y, Chen X. Glibenclamide Ameliorates the Expression of Neurotrophic Factors in Sevoflurane Anaesthesia-induced Oxidative Stress and Cognitive Impairment in Hippocampal Neurons of Old Rats. J Vet Res. 2021 Dec 2;65(4):527-538. doi: 10.2478/jvetres-2021-0064. PMID: 35112009; PMCID: PMC8775723. 2. Jiang B, Zhang Y, Wang Y, Li Z, Chen Q, Tang J, Zhu G. Glibenclamide Attenuates Neuroinflammation and Promotes Neurological Recovery After Intracerebral Hemorrhage in Aged Rats. Front Aging Neurosci. 2021 Aug 26;13:729652. doi: 10.3389/fnagi.2021.729652. PMID: 34512312; PMCID: PMC8427510.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Bircsak KM, Gupta V, Yuen PY, Gorczyca L, Weinberger BI, Vetrano AM, Aleksunes LM. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental BCRP Transporter. J Pharmacol Exp Ther. 2016 Feb 5. pii: jpet.115.230185. [Epub ahead of print] PubMed PMID: 26850786.

2: Sheth KN, Elm JJ, Beslow LA, Sze GK, Kimberly WT. Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design. Neurocrit Care. 2016 Feb;24(1):132-9. doi: 10.1007/s12028-015-0189-7. PubMed PMID: 26268138.

3: Harper LM, Glover AV, Biggio JR, Tita A. Predicting failure of glyburide therapy in gestational diabetes. J Perinatol. 2016 Jan 21. doi: 10.1038/jp.2015.216. [Epub ahead of print] PubMed PMID: 26796130.

4: Rezai S, Vielman M, Henderson CE. Glyburide vs Insulin and Adverse Pregnancy
Outcomes. JAMA Pediatr. 2015 Oct;169(10):974-5. doi:
10.1001/jamapediatrics.2015.1808. PubMed PMID: 26437012.

5: Tuccori M, Wu JW, Yin H, Majdan A, Azoulay L. The Use of Glyburide Compared
With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.
Diabetes Care. 2015 Nov;38(11):2083-9. doi: 10.2337/dc15-1358. Epub 2015 Sep 4.
PubMed PMID: 26341130.